These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 7747724
1. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Freedman BI, Tuttle AB, Spray BJ. Am J Kidney Dis; 1995 May; 25(5):710-3. PubMed ID: 7747724 [Abstract] [Full Text] [Related]
2. The familial risk of end-stage renal disease in African Americans. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM. Am J Kidney Dis; 1993 Apr; 21(4):387-93. PubMed ID: 8465818 [Abstract] [Full Text] [Related]
3. Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy. Leak TS, Langefeld CD, Keene KL, Gallagher CJ, Lu L, Mychaleckyj JC, Rich SS, Freedman BI, Bowden DW, Sale MM. BMC Med Genet; 2010 Feb 08; 11():22. PubMed ID: 20144192 [Abstract] [Full Text] [Related]
4. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Freedman BI, Wilson CH, Spray BJ, Tuttle AB, Olorenshaw IM, Kammer GM. Am J Kidney Dis; 1997 May 08; 29(5):729-32. PubMed ID: 9159307 [Abstract] [Full Text] [Related]
5. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Pugh JA, Medina RA, Cornell JC, Basu S. Diabetes; 1995 Dec 08; 44(12):1375-80. PubMed ID: 7589841 [Abstract] [Full Text] [Related]
6. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. JAMA; 1992 Dec 02; 268(21):3079-84. PubMed ID: 1433738 [Abstract] [Full Text] [Related]
7. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, Langefeld CD, Freedman BI, Rich SS, Bowden DW, Sale MM. Diabetes; 2008 Apr 02; 57(4):1057-62. PubMed ID: 18184924 [Abstract] [Full Text] [Related]
8. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease. Lopes AA, Port FK. Am J Kidney Dis; 1995 Feb 02; 25(2):350-6. PubMed ID: 7847366 [Abstract] [Full Text] [Related]
9. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW, Freedman BI. Kidney Int; 2011 Dec 02; 80(12):1339-43. PubMed ID: 21849968 [Abstract] [Full Text] [Related]
10. Genetic determinants of diabetic nephropathy: The family investigation of nephropathy and diabetes (FIND). Family Investigation of Nephropathy and Diabetes Research Group. J Am Soc Nephrol; 2003 Jul 02; 14(7 Suppl 2):S202-4. PubMed ID: 12819329 [Abstract] [Full Text] [Related]
11. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW. Nephrol Dial Transplant; 2000 Nov 02; 15(11):1794-800. PubMed ID: 11071967 [Abstract] [Full Text] [Related]
12. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW. Nephrol Dial Transplant; 2009 Nov 02; 24(11):3366-71. PubMed ID: 19567477 [Abstract] [Full Text] [Related]
13. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans. Bonomo JA, Ng MC, Palmer ND, Keaton JM, Larsen CP, Hicks PJ, T2D-GENES Consortium, Langefeld CD, Freedman BI, Bowden DW. Clin J Am Soc Nephrol; 2014 Aug 07; 9(8):1434-40. PubMed ID: 24948143 [Abstract] [Full Text] [Related]
14. A genome-wide association study for diabetic nephropathy genes in African Americans. McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, Cooke JN, Hester JM, Wing MR, Bostrom MA, Rudock ME, Lewis JP, Talbert ME, Blevins RA, Lu L, Ng MC, Sale MM, Divers J, Langefeld CD, Freedman BI, Bowden DW. Kidney Int; 2011 Mar 07; 79(5):563-72. PubMed ID: 21150874 [Abstract] [Full Text] [Related]
15. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Freedman BI, Soucie JM, Stone SM, Pegram S. Am J Kidney Dis; 1999 Aug 07; 34(2):254-8. PubMed ID: 10430971 [Abstract] [Full Text] [Related]
16. Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population. Cowie CC, Howard BV, Harris MI. Circulation; 1994 Sep 07; 90(3):1185-93. PubMed ID: 8087927 [Abstract] [Full Text] [Related]
17. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans. McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW. Hum Genet; 2009 Aug 07; 126(2):265-75. PubMed ID: 19373489 [Abstract] [Full Text] [Related]
18. Incipient and overt diabetic nephropathy in African Americans with NIDDM. Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skurnick JH. Diabetes Care; 1994 Apr 07; 17(4):297-304. PubMed ID: 8026285 [Abstract] [Full Text] [Related]
19. Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease. Friedman DJ, Talbert ME, Bowden DW, Freedman BI, Mukanya Y, Enjyoji K, Robson SC. Diabetes; 2009 Apr 07; 58(4):999-1006. PubMed ID: 19095759 [Abstract] [Full Text] [Related]
20. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Freedman BI, Yu H, Spray BJ, Rich SS, Rothschild CB, Bowden DW. Kidney Int; 1997 Mar 07; 51(3):819-25. PubMed ID: 9067916 [Abstract] [Full Text] [Related] Page: [Next] [New Search]